GDRX
NASDAQ · Health Care
Goodrx Holdings Inc-Class A
$3.72
+0.23 (+6.59%)
Financial Highlights (FY 2026)
Revenue
767.03M
Net Income
29.31M
Gross Margin
92.8%
Profit Margin
3.8%
Rev Growth
+1.3%
D/E Ratio
0.79
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 92.8% | 92.8% | 36.5% | 36.5% |
| Operating Margin | 11.0% | 9.9% | 9.8% | 10.6% |
| Profit Margin | 3.8% | 3.6% | 8.2% | 9.2% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 767.03M | 757.18M | 348.02M | 354.36M |
| Gross Profit | 711.57M | 702.44M | 126.97M | 129.28M |
| Operating Income | 84.22M | 74.82M | 34.23M | 37.71M |
| Net Income | 29.31M | 26.04M | 28.69M | 32.45M |
| Gross Margin | 92.8% | 92.8% | 36.5% | 36.5% |
| Operating Margin | 11.0% | 9.9% | 9.8% | 10.6% |
| Profit Margin | 3.8% | 3.6% | 8.2% | 9.2% |
| Rev Growth | +1.3% | +1.3% | +17.9% | +14.4% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 263.53M | 263.53M | 344.40M | 295.15M |
| Total Equity | 332.62M | 332.62M | 683.48M | 611.71M |
| D/E Ratio | 0.79 | 0.79 | 0.50 | 0.48 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 166.24M | 155.90M | 58.27M | 51.67M |
| Free Cash Flow | — | — | 25.71M | 22.62M |